Zydus Pharmaceuticals receives final approval for Valacyclovir Tablets
From USFDA
Zydus Pharmaceuticals, a wholly owned subsidiary of Cadila Healthcare has received the final approval from the USFDA to market Valacyclovir Tablets USP in strengths of 500 mg and 1 gm. The drug is indicated for the treatment of cold sores, genital herpes, chickenpox and herpes zoster.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content